Concord Biotech

Concord Biotech Ltd Quarterly Results

NSEBSE

₹1,604.1

(0.38%)

Aug 11, 2025|12:00:00 AM

Invest wise with Expert advice

Financials

ConsolidatedStandalone

Select Period

Particulars (Rupees in Crores.)	Jun-2025	Mar-2025	Dec-2024	Sept-2024	Jun-2024
Gross Sales	203.99	429.88	244.22	310.18	215.8
Excise Duty	0	0	0	0	0
Net Sales	203.99	429.88	244.22	310.18	215.8
Other Operating Income	0	0	0	0	0
Other Income	15.17	9.38	16.56	10.03	11.66
Total Income	219.16	439.27	260.78	320.21	227.46
Total Expenditure	142.59	241.01	146.27	176.46	134.52
PBIDT	76.57	198.26	114.51	143.75	92.94
Interest	0.06	0.1	0.1	0.1	0.24
PBDT	76.51	198.16	114.42	143.65	92.7
Depreciation	17.78	14.62	13.26	13.31	13.18
Minority Interest Before NP	0	0	0	0	0
Tax	14.08	41.82	23.69	34.06	19.39
Deferred Tax	0.6	1.34	1.54	0.53	0.53
Reported Profit After Tax	44.06	140.39	75.92	95.74	59.59
Minority Interest After NP	0	0	0	0	0
Net Profit after Minority Interest	44.06	140.39	75.92	95.74	59.59
Extra-ordinary Items	0	0	0	0	0
Adjusted Profit After Extra-ordinary item	44.06	140.39	75.92	95.74	59.59
EPS (Unit Curr.)	4.21	13.42	7.26	9.15	5.7
Book Value (Unit Curr.)	0	0	0	0	0
Dividend (%)	0	0	0	0	0
Equity	10.46	10.46	10.46	10.46	10.46
Public Shareholding (Number)	0	0	0	0	0
Public Shareholding (%)	0	0	0	0	0
Pledged/Encumbered - No. of Shares	0	0	0	0	0
Pledged/Encumbered - % in Total Promoters Holding	0	0	0	0	0
Pledged/Encumbered - % in Total Equity	0	0	0	0	0
Non Encumbered - No. of Shares	0	0	0	0	0
Non Encumbered - % in Total Promoters Holding	0	0	0	0	0
Non Encumbered - % in Total Equity	0	0	0	0	0
PBIDTM(%)	37.53	46.11	46.88	46.34	43.06
PBDTM(%)	37.5	46.09	46.85	46.31	42.95
PATM(%)	21.59	32.65	31.08	30.86	27.61